Sex hormones may affect COVID-19 severity and outcomes.
December 2023 in “Regenerative Therapy” Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.
April 2023 in “International Journal of Community Medicine and Public Health” Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.
COVID-19 may trigger or worsen rapid hair loss in alopecia areata.
November 2022 in “Medicina” COVID-19 may cause temporary hair loss due to the body's immune response.
November 2022 in “JAAD Case Reports” COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.
June 2022 in “Plastic and Reconstructive Surgery – Global Open” Stem cell serum effectively treated hair loss caused by COVID-19.
April 2022 in “DOAJ (DOAJ: Directory of Open Access Journals)” Effective hair regrowth after COVID-19 involves psychological support, good nutrition, and hair growth treatments.
January 2022 in “Turkiye Klinikleri Journal of Dermatology” COVID-19 patients with skin signs often stayed in the hospital for less time than those without skin signs.
January 2021 in “Holistic Nursing Practice” COVID-19 can cause hair loss, loss of taste and smell, skin changes, and eye problems.
42 citations
,
July 2021 in “Frontiers in Medicine” Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.
19 citations
,
December 2021 in “Cureus” Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.
13 citations
,
June 2020 in “Journal of Cosmetic Dermatology” The article suggests using safety measures and telemedicine for aesthetic dermatology during COVID-19, while some procedures can still be done safely.
7 citations
,
July 2020 in “Dermatologic Therapy” Dermatologists helped identify COVID-19 through skin symptoms and managed skin issues during the pandemic, but more high-quality research is needed.
4 citations
,
June 2022 in “BioMed Research International” Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.
2 citations
,
September 2022 in “PubMed” Most skin reactions to COVID-19 vaccines in India were mild and not a reason to avoid vaccination.
1 citations
,
March 2023 in “JMIR. Journal of medical internet research/Journal of medical internet research” Social media data can help track COVID-19 symptoms and predict the pandemic's status.
January 2024 in “Future postharvest and food” Frankincense may help treat COVID-19, but more research is needed.
May 2023 in “Clinical and translational neuroscience” Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.
July 2022 in “Jurnal Farmasi Galenika (Galenika Journal of Pharmacy)” Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.
July 2022 in “Jurnal Farmasi Galenika (Galenika Journal of Pharmacy)” Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.
September 2021 in “Journal of Education, Health and Sport”
June 2020 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature”
31 citations
,
July 2020 in “Dermatologic Therapy” Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.
20 citations
,
March 2022 in “Journal of clinical medicine” Nearly half of the studied men with long COVID had low testosterone, including younger men.
16 citations
,
November 2020 in “PLOS ONE” Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.
4 citations
,
May 2022 in “Medicina” Kampo medicine can help treat general fatigue from long COVID.
2 citations
,
October 2022 in “Current Dermatology Reports” People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.
2 citations
,
December 2021 in “Skin health and disease”
1 citations
,
January 2023 in “Revista da Associação Médica Brasileira” Experts agree on the need for standardized definitions and education for post-COVID-19 conditions.